Wednesday, April 04, 2012

Cord blood stem cell clinical trial for hearing loss begins

US researchers have received approval to test whether cord blood stem cells could be used to reverse hearing loss in children.

The phase I clinical trial, the first cord blood trial to be given the go-ahead by the US Food and Drug Administration (FDA), will determine the safety of the treatment.

More at

No comments:

Post a Comment